echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > 【Cell Sub-journal】The latest review study of Professor Fang Jingyuan's team of Shanghai Jiaotong University on the prevention and treatment targets of colorectal cancer

    【Cell Sub-journal】The latest review study of Professor Fang Jingyuan's team of Shanghai Jiaotong University on the prevention and treatment targets of colorectal cancer

    • Last Update: 2022-09-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is the original of translational medicine network, please indicate the source when reprinting

    Author: Jevin

    Colorectal cancer (CRC) is one of the most common cancers with complex causes


    Recently, Professor Fang Jingyuan's team from Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine published a latest review in Trends in Microbiology, summarizing the biological characteristics and regulatory mechanisms of the development of Clostridium nucleated bacterium in colorectal cancer (CRC), and using Clostridium nucleated as a marker for early warning and prognosis prediction of


    cancer

     01 

    Colorectal cancer is the third most common cancer with complex causes


    Doctors often use chemotherapy to treat cancer patients because it eventually induces tumor cell death


    Clostridium nucleated

     02

    Clostridium nucleated is a common oral anaerobic bacillus that is enriched


    Biomarkers and control targets

     03 

    The gastrointestinal pathway is the main route for tissue colonization of Nucleated Clostridium tuberculosis colorectal cancer, and its virulence proteins FadeA and Fap2 are mainly involved in their adhesion


    At the same time, Clostridium nucleated nucleated bacterium can be used as a marker for early warning, early diagnosis and prognosis prediction of


    Resources:

    This article is intended to introduce the progress of medical research and cannot be used as a reference for


    Testimonials/ Live Events

    September 27, 14:00-17:30 Shanghai

    Innovative technology to help tumor accurate diagnosis and treatment summit forum

    Scan the code to participate for free

    November 03-04 09:00-17:30 Shanghai

    The 3rd Yangtze River Delta In Vitro Diagnostic Industry Forum

    Scan the code to participate for free

    November 25-27 09:00-17:30 Shanghai

    The 4th Shanghai International Conference on Cancer

    Scan the code to participate

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.